Categories | Procedure-related characteristics (n = 42) | Test characteristics (n = 23) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Attributes | Procedure | Frequency | Preparation | Location | Follow-up test required | Duration | Mode of test delivery | Purpose | Sensitivity | Specificity | 1-Speificity | 1-Sensitivity | Proportion of false positives in relation to all screenees |
Total number of attributes | 13 | 12 | 10 | 2 | 2 | 1 | 1 | 1 | 12 | 4 | 2 | 1 | 4 |
Rating | |||||||||||||
Hawley et al., 2008 [46] | 1a | 1 | 1 | Â | Â | Â | Â | Â | 1b | Â | Â | Â | Â |
Ranking | |||||||||||||
Gyrd-Hansen et al., 2001 [58] | Â | 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 1c |
Discrete choice | |||||||||||||
Generic | |||||||||||||
Salkeld et al., 2000 [55] | Â | Â | 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â | 1d |
Salkeld et al., 2003 [56] | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 1e |
Marshall et al., 2007 [39] | 1 | Â | 1 | Â | Â | Â | Â | Â | 1 | 1 | Â | Â | Â |
Howard et al., 2009 [43] | 1 | Â | 1 | Â | Â | Â | Â | Â | 2 | 1 | Â | Â | Â |
Marshall et al., 2009 [47] | 1a | 1 | 1 | Â | 1 | Â | Â | Â | 1 | 1 | Â | Â | Â |
Van Dam et al., 2010 [36] | Â | 1 | 1 | 1 | Â | 1 | Â | Â | Â | Â | Â | Â | Â |
Nayaradou et al., 2010 [59] | 1 | Â | Â | Â | Â | Â | 1 | Â | 1 | Â | Â | Â | 1f |
Pignone et al., 2012 [44] | 1a | 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Brenner et al., 2014 [45] | 1a | 1 | Â | Â | 1 | Â | Â | Â | Â | Â | Â | Â | Â |
Groothuis-Oudshoorn et al., 2014 [53] | 1a | 1 | 1 | Â | Â | Â | Â | Â | 1 | 1 | Â | Â | Â |
Pignone et al., 2014 [48] | 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Kistler et al., 2015 [49] | 1a | 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Martens et al., 2016 [50] | 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Osborne et al., 2018 [57] | 1 | Â | Â | Â | Â | Â | Â | Â | 1b | Â | Â | Â | Â |
Mansfield et al., 2018 [51] | Â | Â | 1 | Â | Â | Â | Â | 1 | 1a,b | Â | Â | Â | Â |
Ramezani_Doroh et al., 2019 [60] | 1a | 1 | 1 | 1 | Â | Â | Â | Â | 1 | Â | Â | Â | Â |
De Bekker-Grob et al., 2019 [41] | Â | 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â | 1 | Â |
Phisalprapa et al., 2021 [61] | Â | 1 | 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Labelled | |||||||||||||
Hol et al., 2010 [38] | Â | 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Benning et al., 2014 [52] | Â | Â | Â | Â | Â | Â | Â | Â | 1 | Â | 1 | Â | Â |
Benning et al., 2014 [54] | Â | Â | Â | Â | Â | Â | Â | Â | 1 | Â | 1 | Â | Â |
Categories | Benefits (n = 13) | Harms (n = 16) | Structural characteristics of health care (n = 24) |  | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Attributes | Reduction in colorectal cancer mortality (and incidence) | Colorectal cancer survival | Test-related pain and/or discomfort | Risk of complications | Out-of-pocket costs | Information processes | Travel time to screening facility | Waiting time for follow-up-test | Supervision | Level of evidence |
Total number of attributes | 12 | 1 | 8 | 8 | 15 | 5 | 2 | 1 | 1 | 2 |
Rating | Â | |||||||||
Hawley et al., 2008 [46] | Â | Â | 1 | Â | Â | Â | Â | Â | Â | Â |
Ranking | Â | |||||||||
Gyrd-Hansen et al., 2001 [58] | 1 | Â | Â | Â | 1 | Â | Â | Â | Â | Â |
Discrete choice | ||||||||||
Generic | ||||||||||
Salkeld et al., 2000 [55] | Â | Â | Â | Â | 1 | 1 | Â | Â | 1 | Â |
Salkeld et al., 2003 [56] | 1 | Â | Â | Â | Â | 1 | Â | Â | Â | Â |
Marshall et al., 2007 [39] | Â | Â | 1 | Â | 1 | Â | Â | Â | Â | Â |
Howard et al., 2009 [43] | Â | Â | Â | Â | 1 | Â | Â | Â | Â | Â |
Marshall et al., 2009 [47] | Â | Â | 1 | 1 | 1 | Â | Â | Â | Â | Â |
Van Dam et al., 2010 [36] | 1 | Â | 1 | 1 | Â | Â | Â | Â | Â | Â |
Nayaradou et al., 2010 [59] | 1 | Â | Â | Â | 1 | 1 | Â | Â | Â | Â |
Pignone et al., 2012 [44] | 1a | Â | 1 | 1 | 1 | Â | Â | Â | Â | Â |
Brenner et al., 2014 [45] | 1a | Â | Â | 1 | Â | Â | Â | Â | Â | Â |
Groothuis-Oudshoorn et al., 2014 [53] | Â | Â | Â | 1 | Â | Â | Â | Â | Â | Â |
Pignone et al., 2014 [48] | Â | Â | Â | Â | 2 | Â | 1 | Â | Â | Â |
Kistler et al., 2015 [49] | 1 | Â | Â | 1 | Â | Â | Â | Â | Â | Â |
Martens et al., 2016 [50] | Â | Â | Â | Â | 2 | Â | 1 | Â | Â | Â |
Osborne et al., 2018 [57] | Â | Â | Â | Â | 1 | Â | Â | Â | Â | Â |
Mansfield et al., 2018 [51] | Â | Â | 1a | Â | 1 | Â | Â | Â | Â | Â |
Ramezani_Doroh et al., 2019 [60] | 1 | Â | 1 | 1 | 1 | Â | Â | Â | Â | Â |
De Bekker-Grob et al., 2019 [41] | Â | 1 | Â | Â | Â | 1 | Â | 1 | Â | Â |
Phisalprapa et al., 2021 [61] | 1 | Â | 1 | 1 | 1 | Â | Â | Â | Â | Â |
Labelled | ||||||||||
Hol et al., 2010 [38] | 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Benning et al., 2014 [52] | 1 | Â | Â | Â | Â | Â | Â | Â | Â | 1 |
Benning et al., 2014 [54] | 1 | Â | Â | Â | Â | 1 | Â | Â | Â | 1 |